Till startsida


  • Patients at Emergency Departments Regarded as "Symptoms"

    [25 Nov 2014] The healthcare work of providing care at Emergency departments is medicalized and result-driven. As a consequence of this, patients are regarded as "symptoms", and are shunted around the department as "production units". These are the conclusions of a thesis presented at the Sahlgrenska Academy.

  • Few Operations for Epilepsy despite Their Safety and Efficacy

    [13 Nov 2014] A study at Sahlgrenska Academy has found that epilepsy surgery is a safe, effective and low-risk procedure. Nevertheless, few Swedes have the operation, and those who are interested may have to wait a long time for presurgical counseling.

  • Mapping the spread of diarrhoea bacteria a major step towards new vaccine

    [10 Nov 2014] Every year hundreds of thousands of people die from diarrhoeal diseases caused by ETEC bacteria. A study published in Nature Genetics describes how Swedish researchers have mapped the spread of strains of ETEC bacteria around the world. It provides key information about how pathogenic bacteria arise, which will be important for the Swedish diarrhoea vaccine currently under development.

  • Low Levels of the DHEA Prohormone Predict Coronary Heart Disease

    [6 Nov 2014] Men with low levels of DHEA in the blood run an increased risk of developing coronary heart disease events. The Sahlgrenska Academy study has been published in the Journal of the American College of Cardiology.

  • Promising Steps Toward Combination Treatment of Deadly Pediatric Cancer

    [4 Nov 2014] Anaplastic lymphoma kinase (ALK) activity has been identified as one of the basic processes in neuroblastoma, which accounts for approximately 15% of all fatal cases of pediatric cancer. A study published in Science Signaling by researchers at Sahlgrenska Academy points the way to targeting ALK in treatment of the deadly disease.

More news

Media contacts

Krister Svahn
Press Officer
at Sahlgrenska Academy
Mobile: +46 766 18 38 69
Phone: +46 31 786 3869

To the top